Results 301 to 310 of about 199,379 (359)
The molecular mechanisms of defensive‐grade organic acid biosynthesis in ground beetles
Formic acid and methacrylic acid are the primary defensive chemicals in the pygidial gland secretions of Platynus angustatus and Pterostichus moestus, respectively. Comparative transcriptomics suggests the folate cycle and valine catabolism may be involved in the biosynthesis of formic acid and methacrylic acid, respectively.
Adam M. Rork+3 more
wiley +1 more source
Efficacy analysis of folic acid in chronic atrophic gastritis with Helicobacter pylori infection: a systematic review and meta-analysis. [PDF]
Li H, Li J, Lai M.
europepmc +1 more source
Economic burden of sickle cell disease in Australia
Abstract Background Sickle cell disease (SCD) is an inherited condition that impairs red blood cell function, posing a substantial health burden on patients. As the prevalence of SCD in Australia rises due to migration, discussions surrounding treatment and management strategies are becoming more prominent. Aims Australia lacks a dedicated study on the
Steve Nwokeocha+16 more
wiley +1 more source
Folic acid supplementation in European women of reproductive age and during pregnancy with excessive weight: a systematic review. [PDF]
Loperfido F+8 more
europepmc +1 more source
Abstract Background The main goal of the nasoalveolar molding (NAM) is to mitigate the initial severity of the cleft, facilitating the subsequent surgical procedures. Nevertheless, the use of the appliance entails high stress levels for families. Aim The aim of this study was to assess the perceptions, attitudes, and opinions of parents whose cleft ...
Ana Martínez‐Orellana+6 more
wiley +1 more source
Folic acid supplementation in children with sickle cell disease: a randomized double-blind noninferiority cross-over trial. [PDF]
Williams BA+7 more
europepmc +1 more source
European Guideline (EuroGuiDerm) on atopic eczema: Living update
The updated guideline includes a new evidence‐based recommendation for the IL‐13 inhibitor lebrikizumab. In addition, the Janus kinase inhibitors baricitinib and abrocitinib, which were initially only approved for adult patients, are now also recommended for children from the age of 2 and adolescents from the age of 12, respectively.
A. Wollenberg+31 more
wiley +1 more source
A qualitative assessment of barriers to iron and folic acid supplementation among pregnant women in Botswana. [PDF]
Kebaabetswe P+11 more
europepmc +1 more source